Fragment of the glycoprotein CD55/DAF for producing highly effective anti-tumour medicaments and method for using the same

Details for Australian Patent Application No. 2004203479 (hide)

International Classifications

Event Publications

12 August 2004 Complete Application Filed

26 August 2004 Application Open to Public Inspection

Published as AU-A-2004203479

20 January 2005 Assignment before Grant

Vollmers, Heinz; Muller-Hermelink, Hans The application has been assigned to H3 Pharma Inc.

17 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.